摘要
近年来,随着肿瘤生物学和细胞生物学的发展,越来越多的抗肿瘤新靶点被发现,把它们作为药物设计的基础,为肿瘤治疗提供新途径。本文就VEGF/VEGFR、Survivin、端粒酶这几个靶点的研究进展作一简述。
In recent years,along with the rapidly increased knowledge of tumor biology and cell biology, more and more the new targets for anti-tumor was found and used as the bases for drug design, which provide a new way for tumor therapy. Here we summarize recent information on VEGF/VEGFR, Survivin, Telomerase, which have the potential of anti-tumor effect.
出处
《中国现代药物应用》
2009年第11期205-207,共3页
Chinese Journal of Modern Drug Application
